Preliminary Study of the Possible Benefit of the Reversible Acetylcholinesterase Inhibitor Donepezil for Cognitive Impairment Associated with Corticorticosteroid Treatment for Presumptive Neurosarcoidsosis with a Lesion in the Right Basal Ganglia and Thalamus
- DOI
- 10.9734/bjmmr/2017/33821
- Published
- 2017-01-10
- Container
- British Journal of Medicine and Medical Research
- Publisher
- Sciencedomain International
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.9734/bjmmr/2017/33821,
title = {Preliminary Study of the Possible Benefit of the Reversible Acetylcholinesterase Inhibitor Donepezil for Cognitive Impairment Associated with Corticorticosteroid Treatment for Presumptive Neurosarcoidsosis with a Lesion in the Right Basal Ganglia and Thalamus},
author = {Laurie Moore and Mila Goldner- Vukov and Rachel Huso and Risa Ishino and Samuel Althauser},
year = {2017},
journal = {British Journal of Medicine and Medical Research},
doi = {10.9734/bjmmr/2017/33821},
url = {https://doi.org/10.9734/bjmmr/2017/33821}
}RIS
TY - JOUR TI - Preliminary Study of the Possible Benefit of the Reversible Acetylcholinesterase Inhibitor Donepezil for Cognitive Impairment Associated with Corticorticosteroid Treatment for Presumptive Neurosarcoidsosis with a Lesion in the Right Basal Ganglia and Thalamus AU - Laurie Moore AU - Mila Goldner- Vukov AU - Rachel Huso AU - Risa Ishino AU - Samuel Althauser PY - 2017 JO - British Journal of Medicine and Medical Research DO - 10.9734/bjmmr/2017/33821 UR - https://doi.org/10.9734/bjmmr/2017/33821 ER -
APA
Moore, L., Vukov, M. G., Huso, R., Ishino, R., & Althauser, S. (2017). Preliminary Study of the Possible Benefit of the Reversible Acetylcholinesterase Inhibitor Donepezil for Cognitive Impairment Associated with Corticorticosteroid Treatment for Presumptive Neurosarcoidsosis with a Lesion in the Right Basal Ganglia and Thalamus. British Journal of Medicine and Medical Research. https://doi.org/10.9734/bjmmr/2017/33821
Source records
- crossref · retrieved 2026-09-26T13:51:41.156Z